RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Avadel Pharmaceuticals Employees 2024

Avadel Pharmaceuticals Employees

50

Avadel Pharmaceuticals Dividend yield

Ticker

AVDL

ISIN

US05337M1045

WKN

A2DJR8

In 2024, Avadel Pharmaceuticals employed 50 people, a 0% change from the 50 number of employees in the previous year.

Avadel Pharmaceuticals Aktienanalyse

What does Avadel Pharmaceuticals do?

Avadel Pharmaceuticals PLC is an Irish pharmaceutical company that focuses on the development, manufacturing, and marketing of pharmaceutical products. The company was founded in 1999 under the name Flamel Technologies and was renamed Avadel Pharmaceuticals in 2019 to support its rebranding strategy and expand its activities in the global market. Avadel's business model is based on the discovery and development of therapies for rare diseases and sleep-related disorders, as well as the manufacturing and marketing of generic drugs and specialty products. The company is divided into three main segments: specialty pharmaceuticals, generic pharmaceuticals, and the Pediarix division. Avadel's specialty pharmaceuticals segment focuses on developing drugs for patients with rare diseases such as Prader-Willi syndrome or narcolepsy. An example of an innovative product in this segment is Rekarbri, an ORP medication for the treatment of narcolepsy. It is the first drug in the EU specifically tailored to the specific needs of narcolepsy patients and has improved patients' quality of life. The generic pharmaceuticals segment of Avadel offers high-quality and cost-effective medications that treat commonly prescribed and everyday conditions such as pain, infections, depression, and anxiety disorders. Most products in this segment are manufactured in the USA and are available in many countries worldwide. Avadel's Pediarix division specializes in the development and manufacturing of children's medicines. This includes products for the treatment of attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASD). An example of a product from this segment is Reagila, a medication for the treatment of ADHD in children that is known for its improved efficacy and lower risk of side effects. Avadel also has a geographically distributed business structure that allows it to market its products worldwide. The company has a strong presence in the USA and is represented in Europe, Asia, and Australia. It has an impressive research and development infrastructure, including manufacturing facilities and research facilities, that allow it to meet the needs of its customers. Overall, Avadel Pharmaceuticals is a leading pharmaceutical company that focuses on researching new and innovative therapies for patients with rare diseases and sleep-related disorders. The company has demonstrated its ability to bring effective products to the market while maintaining the highest standards in quality assurance and customer service. It is expected that Avadel will continue to grow in the future and introduce new and innovative products to help its customers and patients worldwide. Avadel Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Avadel Pharmaceuticals's Employee Base

Avadel Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Avadel Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Avadel Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Avadel Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Avadel Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Avadel Pharmaceuticals Stock

How many employees does Avadel Pharmaceuticals have this year?

Avadel Pharmaceuticals has 50 undefined employees this year.

How many employees did Avadel Pharmaceuticals have compared to the previous year?

Compared to the previous year, Avadel Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Avadel Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Avadel Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Avadel Pharmaceuticals?

The number of employees can also have an impact on investors of Avadel Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Avadel Pharmaceuticals affect the company?

An increase in equity of Avadel Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Avadel Pharmaceuticals's equity affect the company?

A reduction in equity of Avadel Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Avadel Pharmaceuticals?

Some factors that can influence the equity of Avadel Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Avadel Pharmaceuticals so important for investors?

The equity of Avadel Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Avadel Pharmaceuticals influence the company?

The number of employees at Avadel Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Avadel Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Avadel Pharmaceuticals has changed by 0.

How many employees does Avadel Pharmaceuticals currently have?

Avadel Pharmaceuticals currently has 50 undefined employees.

Why is the number of employees important for investors of Avadel Pharmaceuticals?

The number of employees is important for investors of Avadel Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Avadel Pharmaceuticals take to change the number of employees?

To change the number of employees, Avadel Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Avadel Pharmaceuticals pay?

Over the past 12 months, Avadel Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avadel Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Avadel Pharmaceuticals?

The current dividend yield of Avadel Pharmaceuticals is .

When does Avadel Pharmaceuticals pay dividends?

Avadel Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avadel Pharmaceuticals?

Avadel Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Avadel Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avadel Pharmaceuticals located?

Avadel Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avadel Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avadel Pharmaceuticals from 5/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/16/2024.

When did Avadel Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/16/2024.

What was the dividend of Avadel Pharmaceuticals in the year 2023?

In the year 2023, Avadel Pharmaceuticals distributed 0 USD as dividends.

In which currency does Avadel Pharmaceuticals pay out the dividend?

The dividends of Avadel Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Avadel Pharmaceuticals

Our stock analysis for Avadel Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avadel Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.